Retatrutide Dosing Overview
Getting your retatrutide dose right is critical for both safety and results. Unlike some peptides where dosing is weight-based from day one, retatrutide uses a fixed titration protocol — everyone starts at the same dose and gradually increases over weeks. This approach minimizes gastrointestinal side effects while allowing your body to adapt to each dose level.
This guide covers everything you need to calculate exact injection volumes based on your reconstitution setup, understand the titration timeline, and make informed decisions about dose adjustments.
The Standard Titration Protocol
The retatrutide titration schedule used in clinical trials follows a structured escalation over 20+ weeks:
Phase 1: Initiation (Weeks 1-4) — 1mg/week
- Purpose: Allow your body to recognize and respond to GLP-1/GIP/glucagon receptor activation
- What to expect: Mild appetite changes, minimal side effects for most users
- Do not skip this phase even if you've used other GLP-1 agonists before
Phase 2: Early Escalation (Weeks 5-8) — 2mg/week
- Purpose: Begin meaningful receptor activation
- What to expect: Noticeable appetite suppression, possible mild nausea
- This is where most users first notice food cravings decreasing
Phase 3: Mid Escalation (Weeks 9-12) — 4mg/week
- Purpose: Reach therapeutic threshold where significant weight loss begins
- What to expect: Strong appetite suppression, measurable weight loss (5-10% typical by end of this phase)
- GI side effects may peak during transition — this is normal and usually subsides within 1-2 weeks
Phase 4: Advanced Escalation (Weeks 13-16) — 6mg/week
- Purpose: Approach full therapeutic dose
- What to expect: Continued steady weight loss, potential food aversion to high-calorie items
Phase 5: High Dose (Weeks 17-20) — 8mg/week
- Purpose: Reach target therapeutic dose for most users
- What to expect: Significant ongoing weight loss, well-adapted to side effect profile
Phase 6: Maximum/Maintenance (Week 21+) — 8-12mg/week
- Purpose: Achieve and maintain maximum weight loss
- Not all users need 12mg — many achieve excellent results at 8mg maintenance
- Adjust based on: Continued weight loss progress, side effect tolerance, healthcare provider guidance
Injection Volume Calculator
The volume you inject depends on two things: your current dose and your reconstitution concentration. Here are complete lookup tables for the two most common setups.
Option A: Standard Reconstitution (2mL BAC water in 10mg vial = 5mg/mL)
| Dose | Calculation | Volume to Draw | Syringe Units (100-unit syringe) |
|---|---|---|---|
| 0.5mg | 0.5 ÷ 5 = 0.1mL | 0.10mL | 10 units |
| 1mg | 1 ÷ 5 = 0.2mL | 0.20mL | 20 units |
| 2mg | 2 ÷ 5 = 0.4mL | 0.40mL | 40 units |
| 3mg | 3 ÷ 5 = 0.6mL | 0.60mL | 60 units |
| 4mg | 4 ÷ 5 = 0.8mL | 0.80mL | 80 units |
| 5mg | 5 ÷ 5 = 1.0mL | 1.00mL | 100 units |
| 6mg | 6 ÷ 5 = 1.2mL | 1.20mL | Split into 2 injections |
| 8mg | 8 ÷ 5 = 1.6mL | 1.60mL | Split into 2 injections |
| 10mg | 10 ÷ 5 = 2.0mL | 2.00mL | Split into 2 injections |
| 12mg | 12 ÷ 5 = 2.4mL | 2.40mL | Requires 2 vials, split injections |
Option B: Concentrated Reconstitution (1mL BAC water in 10mg vial = 10mg/mL)
| Dose | Calculation | Volume to Draw | Syringe Units (100-unit syringe) |
|---|---|---|---|
| 0.5mg | 0.5 ÷ 10 = 0.05mL | 0.05mL | 5 units |
| 1mg | 1 ÷ 10 = 0.1mL | 0.10mL | 10 units |
| 2mg | 2 ÷ 10 = 0.2mL | 0.20mL | 20 units |
| 3mg | 3 ÷ 10 = 0.3mL | 0.30mL | 30 units |
| 4mg | 4 ÷ 10 = 0.4mL | 0.40mL | 40 units |
| 5mg | 5 ÷ 10 = 0.5mL | 0.50mL | 50 units |
| 6mg | 6 ÷ 10 = 0.6mL | 0.60mL | 60 units |
| 8mg | 8 ÷ 10 = 0.8mL | 0.80mL | 80 units |
| 10mg | 10 ÷ 10 = 1.0mL | 1.00mL | 100 units |
| 12mg | 12 ÷ 10 = 1.2mL | 1.20mL | Split into 2 injections |
The Formula
If you're using a non-standard reconstitution, calculate your injection volume with:
Volume (mL) = Desired Dose (mg) ÷ Concentration (mg/mL)
Concentration (mg/mL) = Total Peptide (mg) ÷ BAC Water Added (mL)
Example: You have a 10mg vial reconstituted with 1.5mL BAC water.
- Concentration = 10 ÷ 1.5 = 6.67mg/mL
- For a 4mg dose: 4 ÷ 6.67 = 0.60mL = 60 units
Which Reconstitution Should You Choose?
Choose 2mL (Standard) If:
- You're starting at 1-4mg doses and want easier measurement
- You prefer larger, more visible markings on the syringe
- This is your first time using injectable peptides
- You plan to stay at moderate doses (up to 5mg)
Choose 1mL (Concentrated) If:
- You plan to escalate to 8-12mg maintenance doses
- You want to avoid splitting injections at higher doses
- You're experienced with precise syringe measurements
- You want the entire vial to last longer at lower doses
Splitting Injections at Higher Doses
When your calculated volume exceeds 1mL (100 units on a standard insulin syringe), you have two options:
Option 1: Split into two injections
- Draw half the total volume in each injection
- Inject at two different sites (e.g., left abdomen and right abdomen)
- Complete both injections within the same session
- This is perfectly safe and does not affect absorption
Option 2: Use a concentrated reconstitution
- Reconstitute with less water to increase concentration
- Allows higher doses in a single injection
- Requires more precise measurement with the syringe
How Many Doses Per Vial?
From a 10mg Vial
| Dose | Doses Per Vial | Weeks Supply |
|---|---|---|
| 1mg | 10 doses | 10 weeks |
| 2mg | 5 doses | 5 weeks |
| 4mg | 2.5 doses | ~2.5 weeks |
| 6mg | 1.67 doses | ~1.5 weeks |
| 8mg | 1.25 doses | ~1 week |
| 10mg | 1 dose | 1 week |
| 12mg | 0.83 doses | Need 2 vials |
Planning tip: For a full 20-week titration from 1mg to 8mg, you'll need approximately 5-6 vials of 10mg retatrutide total.
Dose Adjustment Guidelines
When to Stay at Your Current Dose Longer
- Persistent nausea lasting more than 3-4 days after injection
- Vomiting more than once per week
- Significant fatigue affecting daily function
- Weight loss is already exceeding 1-2% per week at current dose
When to Step Back One Dose Level
- Severe nausea preventing adequate food/fluid intake
- Vomiting multiple times per week
- Diarrhea causing dehydration concerns
- Any side effect rated 7+ out of 10 severity
When NOT to Adjust Dose on Your Own
- If you have diabetes and are on insulin or sulfonylureas (hypoglycemia risk)
- If you experience severe abdominal pain (seek medical attention)
- If you're losing weight faster than 3% per week consistently
- If you have kidney disease or other organ function concerns
Common Dosing Mistakes to Avoid
- Skipping the titration — Starting at 4mg or higher because you "want faster results" leads to severe nausea and often causes people to quit entirely
- Inconsistent injection day — Varying your injection day creates uneven blood levels and worse side effects
- Drawing from a cloudy vial — If the reconstituted solution isn't clear, discard it
- Not accounting for dead space — Insulin syringes have a small amount of dead space in the hub. For very small doses (5-10 units), this can represent a significant portion of your dose. Low-dead-space syringes are available.
- Storing improperly — Reconstituted retatrutide left at room temperature degrades rapidly. Always refrigerate immediately after drawing your dose.
Related Guides
- Retatrutide Complete Guide — Full overview including reconstitution, injection technique, and storage
- Retatrutide Results: What to Expect — Detailed week-by-week timeline
- Retatrutide Side Effects — Complete side effect management strategies
- Retatrutide vs Tirzepatide — How dosing compares between the two peptides
Disclaimer
This dosing information is compiled from published clinical trial protocols and established pharmacological data. It is for educational purposes only and does not constitute medical advice. Individual dosing should be determined in consultation with a qualified healthcare provider. Retatrutide is an investigational compound not yet approved by the FDA or Health Canada.
